Five minutes with… Dmitry Karshtedt
05-07-2021
Five minutes with… Eva Kabir
02-03-2021
Five minutes with… Irena Royzman
25-02-2021
26-11-2020
Amid the unprecedented challenges presented by COVID-19, questions around the use of second medical use (SMU) patents have become increasingly pertinent. On Tuesday December 1, LSPN Connect’s session: Addressing Second Medical Use Infringement: An Evaluation of Recent SMU Cases will examine a number of key issues relating to this pivotal area of life sciences IP.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
LSPN Connect, COVID-19, second medical use, life sciences, infringement, Arnold Porter, Three New Square Intellectual Property, Pfizer, Smart & Biggar
Five minutes with… Dmitry Karshtedt
05-07-2021
Five minutes with… Eva Kabir
02-03-2021
Five minutes with… Irena Royzman
25-02-2021